Suppr超能文献

不同来源的工程化细胞外囊泡用于癌症靶向治疗。

Engineered exosomes from different sources for cancer-targeted therapy.

机构信息

Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450001, China.

Department of Colorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450001, China.

出版信息

Signal Transduct Target Ther. 2023 Mar 15;8(1):124. doi: 10.1038/s41392-023-01382-y.

Abstract

Exosome is a subgroup of extracellular vesicles, which has been serving as an efficient therapeutic tool for various diseases. Engineered exosomes are the sort of exosomes modified with surface decoration and internal therapeutic molecules. After appropriate modification, engineered exosomes are able to deliver antitumor drugs to tumor sites efficiently and precisely with fewer treatment-related adverse effects. However, there still exist many challenges for the clinical translation of engineered exosomes. For instance, what sources and modification strategies could endow exosomes with the most efficient antitumor activity is still poorly understood. Additionally, how to choose appropriately engineered exosomes in different antitumor therapies is another unresolved problem. In this review, we summarized the characteristics of engineered exosomes, especially the spatial and temporal properties. Additionally, we concluded the recent advances in engineered exosomes in the cancer fields, including the sources, isolation technologies, modification strategies, and labeling and imaging methods of engineered exosomes. Furthermore, the applications of engineered exosomes in different antitumor therapies were summarized, such as photodynamic therapy, gene therapy, and immunotherapy. Consequently, the above provides the cancer researchers in this community with the latest ideas on engineered exosome modification and new direction of new drug development, which is prospective to accelerate the clinical translation of engineered exosomes for cancer-targeted therapy.

摘要

外泌体是细胞外囊泡的一个亚群,已被用作治疗各种疾病的有效治疗工具。工程化外泌体是经过表面修饰和内部治疗分子修饰的外泌体。经过适当的修饰,工程化外泌体能够高效、精确地将抗肿瘤药物递送到肿瘤部位,同时减少治疗相关的不良反应。然而,工程化外泌体的临床转化仍然存在许多挑战。例如,什么来源和修饰策略可以赋予外泌体最有效的抗肿瘤活性仍不清楚。此外,如何在不同的抗肿瘤治疗中选择适当的工程化外泌体也是一个尚未解决的问题。在这篇综述中,我们总结了工程化外泌体的特征,特别是时空特性。此外,我们总结了工程化外泌体在癌症领域的最新进展,包括工程化外泌体的来源、分离技术、修饰策略以及标记和成像方法。此外,还总结了工程化外泌体在不同抗肿瘤治疗中的应用,如光动力治疗、基因治疗和免疫治疗。综上所述,为该领域的癌症研究人员提供了关于工程化外泌体修饰的最新思路和新药开发的新方向,有望加速工程化外泌体在癌症靶向治疗中的临床转化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c62/10017761/8412a40ee0d8/41392_2023_1382_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验